BMO Capital Downgrades Graphite Bio Inc (GRPH) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
After-hours movers: CytomX jumps on Moderna deal, WWE gains as McMahon supports possible sale
January 5, 2023 5:42 PM ESTAfter-Hours Movers:
CytomX Therapeutics, Inc. (NASDAQ: CTMX) 52% HIGHER; The company and Moderna, Inc. (NASDAQ: MRNA) announced a collaboration and licensing agreement to create investigational mRNA-based conditionally activated therapies utilizing Moderna's mRNA technologies and CytomX's Probody therapeutic platform.
Fate Therapeutics, Inc.... More
Graphite Corp. (GRPH) Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel
January 5, 2023 4:05 PM EST(Updated - January 5, 2023 4:06 PM EST)
Graphite Bio, Inc. (Nasdaq: GRPH) today announced it is voluntarily pausing the Phase 1/2 CEDAR study of nulabeglogene autogedtemcel (nula-cel) for sickle cell disease (SCD) due to a serious adverse event in the first patient dosed with nula-cel, and the companys conclusion that the event is likely related to study treatment. As a result, the company will not meet its guidance for initial proof-of-concept data in mid-2023.
The decision by Graphite Bio to voluntarily pause the CEDAR study follows a serious and unexpected adverse event of prolonged low blood... More
Graphite Corp. (GRPH) Halted, News Pending
January 5, 2023 4:01 PM ESTGraphite Corp. (NASDAQ: GRPH) Halted, News Pending
